A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum

被引:9
|
作者
Wlodarczyk, J
Bethke, B
Mueller, E
Stolte, M
Mueller, J
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Tech Univ Munich, Klinikum Rechts Isar, Chirurg Klin & Poliklin, D-81675 Munich, Germany
[3] Klinikum Bayreuth, Inst Pathol, D-95445 Bayreuth, Germany
关键词
de novo colorectal carcinoma; E-cadherin; stromelysin-3; immunohistochemistry;
D O I
10.1007/s004280100468
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
An apparent exception to the colorectal adenoma-carcinoma carcinogenetic pathway is the so-called "de novo" carcinoma which has no evidence of adenoma in its vicinity. Despite the fact that they are often quite small, these lesions appear to be more aggressive (i.e., greater likelihood of lymph-node metastases) than carcinomas that clearly arise from surrounding adenomas exadenoma carcinoma. The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression. The rates of extensive ST-3 expression and decreased E-cadherin expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively). Histopathologically, the de novo group also had a-significantly higher percentage of cases with an infiltrative invasion pattern. These differences highlight the more aggressive phenotype of the de novo colorectal carcinoma and fit with their greater invasive potential.
引用
收藏
页码:756 / 761
页数:6
相关论文
共 41 条
  • [31] INT6/eIF3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells
    Gotoh-Saito, Saki
    Sadato, Daichi
    Shibasaki, Futoshi
    GENES TO CELLS, 2022, 27 (12) : 689 - 705
  • [32] Expression of CXCR4, E-Cadherin, Bcl-2, and Survivin in Merkel Cell Carcinoma: An Immunohistochemical Study Using a Tissue Microarray
    Knapp, Charles F.
    Sayegh, Zena
    Schell, Michael J.
    Rawal, Bhupendra
    Ochoa, Tatiana
    Sondak, Vernon K.
    Messina, Jane L.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (06) : 592 - 596
  • [33] 1Alpha,25-dihydroxyvitamin D3 Induces de novo E-cadherin Expression in Triple-negative Breast Cancer Cells by CDH1-promoter Demethylation
    Lopes, Nair
    Carvalho, Joana
    Duraes, Cecilia
    Sousa, Barbara
    Gomes, Madalena
    Costa, Jose Luis
    Oliveira, Carla
    Paredes, Joana
    Schmitt, Fernando
    ANTICANCER RESEARCH, 2012, 32 (01) : 249 - 257
  • [34] E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines
    Nakagawa, Tatsushi
    Murakami, Akihiro
    Torii, Mayumi
    Nawata, Shugo
    Takeda, Osamu
    Sugino, Norihiro
    ONCOLOGY REPORTS, 2007, 18 (01) : 175 - 179
  • [35] T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression
    Feng, Xianguang
    Yao, Wenhuan
    Zhang, Zengzhen
    Yuan, Fangshui
    Liang, Li
    Zhou, Jingqiang
    Liu, Shuang
    Song, Jiqing
    ONCOLOGY RESEARCH, 2018, 26 (06) : 959 - 966
  • [36] E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: Results from a long-term follow-up study
    Cai, Tommaso
    Piazzini, Mauro
    Nesi, Gabriella
    Taddei, Ilaria
    Sardi, Iacopo
    Detti, Beatrice
    Mondaini, Nicola
    Dal Canto, Maurizio
    Bartoletti, Riccardo
    ONCOLOGY REPORTS, 2007, 17 (04) : 925 - 930
  • [37] Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells
    Gagnon, J
    Shaker, S
    Primeau, M
    Hurtubise, A
    Momparler, RL
    ANTI-CANCER DRUGS, 2003, 14 (03) : 193 - 202
  • [38] Expression of GATA3, p63, E-cadherin and Her2Neu Immunohistochemical Stains in Urothelial Carcinoma and their Relationship with Histological Grading and Prognosis- A Cross-sectional Study
    Mukherjee, Debarghya
    Dey, Soumya
    Chatterjee, Souvik
    Mondal, Madhumita
    Singh, Deepali
    Sinha, Mamata Guha Mallick
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (04) : EC13 - EC18
  • [39] LncRNA HOTAIR regulates the expression of E-cadherin to affect nasopharyngeal carcinoma progression by recruiting histone methylase EZH2 to mediate H3K27 trimethylation
    Yang, Feng-Lian
    Wei, Yu-Xia
    Liao, Bi-Yun
    Wei, Gui-Jiang
    Qin, Hai-Mei
    Pang, Xiao-Xia
    Wang, Jun-Li
    GENOMICS, 2021, 113 (04) : 2276 - 2289
  • [40] Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations
    Huang, Hsien-Neng
    Huang, Wen-Chih
    Lin, Ching-Hung
    Chiang, Ying-Cheng
    Huang, Hsin-Ying
    Kuo, Kuan-Ting
    HUMAN PATHOLOGY, 2014, 45 (11) : 2318 - 2325